At Artemis
After joining Artemis in 2018, Olly’s analytical decision making, transaction expertise, and resilient attitude have been integral to Artemis’ exciting growth. His responsibilities include transaction leadership, portfolio company management, investment thesis development, investment team program oversight, and limited partner engagement.
SPECIALIZATION
- Specialty Chemicals
- Sensors & Instrumentation
- Robotics & Automation
- Advanced Materials
PORTFOLIO Companies
- R.M. Lucas
- Tekscan
- BioDot
- STC
Background
Before joining Artemis Olly worked at Canaccord Genuity, providing strategic and transactional services to middle-market technology companies. Before Canaccord, Olly worked in Technology Investment Banking at AGC Partners, a Boston-based investment bank specialized in supporting technology companies. He received his Bachelor of Science degrees in Biochemistry and Molecular Biology from the University of Massachusetts Amherst.
Artemis Insights
-
A Next Generation Optical Coatings Platform
BOSTON, July 7, 2021 – On July 6th, 2021, Omega Optical (Omega or the Platform), Artemis Capital Partners’ (Artemis or
-
Maury Microwave Forms Exciting New Platform for Artemis
BOSTON, July 1, 2021 – On Thursday June 24, 2021, Artemis Capital Partners (Artemis or the Firm) officially announced the
-
Artemis Announces Sale of its Portfolio Company BioDot to ATS
Since its founding in 1994, BioDot has become an undisputed leader in the development of automated, high-throughput, ultra-low volume liquid